| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis
|
Llanos-Cuentas, Alejandro
|
|
2010
|
28 |
Supplement 2 |
p. 7427-7435
9 p.
|
artikel
|
| 2 |
A cost–effectiveness analysis of Japanese encephalitis vaccine in Cambodia
|
Touch, Sok
|
|
2010
|
28 |
Supplement 2 |
p. 4593-4599
7 p.
|
artikel
|
| 3 |
Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive
|
Hutnick, Natalie A.
|
|
2010
|
28 |
Supplement 2 |
p. 1932-1941
10 p.
|
artikel
|
| 4 |
A dynamic model of pneumococcal infection in the United States: Implications for prevention through vaccination
|
Van Effelterre, Thierry
|
|
2010
|
28 |
Supplement 2 |
p. 3650-3660
11 p.
|
artikel
|
| 5 |
Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers
|
van Dissel, Jaap T.
|
|
2010
|
28 |
Supplement 2 |
p. 3571-3581
11 p.
|
artikel
|
| 6 |
Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children
|
Passwell, Justen H.
|
|
2010
|
28 |
Supplement 2 |
p. 2231-2235
|
artikel
|
| 7 |
Antibody persistence six years after two doses of combined hepatitis A and B vaccine
|
Burgess, Margaret A.
|
|
2010
|
28 |
Supplement 2 |
p. 2222-2226
|
artikel
|
| 8 |
A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA
|
Keiser, Paul B.
|
|
2010
|
28 |
Supplement 2 |
p. 6970-6976
7 p.
|
artikel
|
| 9 |
A practical in vitro growth inhibition assay for the evaluation of TB vaccines
|
Kolibab, Kristopher
|
|
2009
|
28 |
Supplement 2 |
p. 317-322
6 p.
|
artikel
|
| 10 |
A preliminary study of chemo- and cytokine responses in rabies vaccine recipients of intradermal and intramuscular regimens
|
Saraya, Abhinbhen
|
|
2010
|
28 |
Supplement 2 |
p. 4553-4557
5 p.
|
artikel
|
| 11 |
A randomized controlled trial of analgesia during vaccination in adults
|
Taddio, Anna
|
|
2010
|
28 |
Supplement 2 |
p. 5365-5369
5 p.
|
artikel
|
| 12 |
A recombinant humanized monoclonal antibody completely protects mice against lethal challenge with Venezuelan equine encephalitis virus
|
Hu, Wei-Gang
|
|
2010
|
28 |
Supplement 2 |
p. 5558-5564
7 p.
|
artikel
|
| 13 |
A universal anti-HIV-1 Tat epitope vaccine that is fully synthetic and self-adjuvanting
|
Goldstein, Gideon
|
|
2010
|
28 |
Supplement 2 |
p. 1008-1014
7 p.
|
artikel
|
| 14 |
A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children
|
Zhu, Wei
|
|
2010
|
28 |
Supplement 2 |
p. 2865-2876
12 p.
|
artikel
|
| 15 |
Bacterial ghosts (BGs)—Advanced antigen and drug delivery system
|
Kudela, Pavol
|
|
2010
|
28 |
Supplement 2 |
p. 5760-5767
8 p.
|
artikel
|
| 16 |
Biochemical characterizations of Escherichia coli-expressed protective antigen Ag473 of Neisseria meningitides group B
|
Sung, Jerry Wang-Chou
|
|
2010
|
28 |
Supplement 2 |
p. 8175-8182
8 p.
|
artikel
|
| 17 |
Bottleneck effects on vaccine-candidate antigen diversity of malaria parasites in Thailand
|
Jongwutiwes, Somchai
|
|
2010
|
28 |
Supplement 2 |
p. 3112-3117
6 p.
|
artikel
|
| 18 |
Carbohydrate moieties as vaccine candidates: Meeting summary
|
Lucas, A.H.
|
|
2010
|
28 |
Supplement 2 |
p. 1121-1131
11 p.
|
artikel
|
| 19 |
CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein
|
Zhao, Kai
|
|
2010
|
28 |
Supplement 2 |
p. 6666-6674
9 p.
|
artikel
|
| 20 |
Cell-mediated immune response and cross-protective efficacy of binary ethylenimine-inactivated bluetongue virus serotype-1 vaccine in sheep
|
Umeshappa, Channakeshava Sokke
|
|
2010
|
28 |
Supplement 2 |
p. 2522-2531
10 p.
|
artikel
|
| 21 |
Characterization and immune effect of the hepatitis B–BCG combined vaccine for using a needle innoculation
|
Jin, Lijie
|
|
2010
|
28 |
Supplement 2 |
p. 6041-6051
11 p.
|
artikel
|
| 22 |
Characterization of ferritin 2 for the control of tick infestations
|
Hajdusek, Ondrej
|
|
2010
|
28 |
Supplement 2 |
p. 2993-2998
6 p.
|
artikel
|
| 23 |
Characterization of foot-and-mouth disease virus antigen by surface-enhanced laser desorption ionization-time of flight-mass spectrometry in aqueous and oil-emulsion formulations
|
Harmsen, M.M.
|
|
2010
|
28 |
Supplement 2 |
p. 3363-3370
8 p.
|
artikel
|
| 24 |
Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity
|
Barnoy, S.
|
|
2010
|
28 |
Supplement 2 |
p. 1642-1654
13 p.
|
artikel
|
| 25 |
Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection
|
Bernard, Matthew P.
|
|
2010
|
28 |
Supplement 2 |
p. 1363-1372
10 p.
|
artikel
|
| 26 |
Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines
|
Steele, A.D.
|
|
2010
|
28 |
Supplement 2 |
p. 6542-6548
7 p.
|
artikel
|
| 27 |
Co-expression of Flt-3 ligand gene ablates tumor immunity elicited by HER-2/neu DNA vaccine in transgenic mice
|
Venanzi, F.M.
|
|
2010
|
28 |
Supplement 2 |
p. 3841-3847
7 p.
|
artikel
|
| 28 |
Comparability of antibody response to a booster dose of 7-valent pneumococcal conjugate vaccine in infants primed with either 2 or 3 doses
|
Rodenburg, Gerwin D.
|
|
2010
|
28 |
Supplement 2 |
p. 1391-1396
6 p.
|
artikel
|
| 29 |
Comparative varicella vaccine effectiveness during outbreaks in day-care centres
|
Spackova, M.
|
|
2010
|
28 |
Supplement 2 |
p. 686-691
6 p.
|
artikel
|
| 30 |
Comparing human T cell and NK cell responses in viral-based malaria vaccine trials
|
Berthoud, Tamara K.
|
|
2009
|
28 |
Supplement 2 |
p. 21-27
7 p.
|
artikel
|
| 31 |
Comparison of commercial and experimental porcine circovirus type 2 (PCV2) vaccines using a triple challenge with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine parvovirus (PPV)
|
Shen, H.G.
|
|
2010
|
28 |
Supplement 2 |
p. 5960-5966
7 p.
|
artikel
|
| 32 |
Comparison of long-term humoral memory development after immunisation against Neisseria meningitidis B or diphtheria toxoid
|
Cruz, Simone C.
|
|
2010
|
28 |
Supplement 2 |
p. 6841-6846
6 p.
|
artikel
|
| 33 |
Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2–10 years of age
|
Halperin, Scott A.
|
|
2010
|
28 |
Supplement 2 |
p. 7865-7872
8 p.
|
artikel
|
| 34 |
Complex cytokine profiles induced by BCG vaccination in UK infants
|
Lalor, Maeve K.
|
|
2010
|
28 |
Supplement 2 |
p. 1635-1641
7 p.
|
artikel
|
| 35 |
Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein
|
Reszka, Natalia J.
|
|
2010
|
28 |
Supplement 2 |
p. 2754-2762
9 p.
|
artikel
|
| 36 |
Construction of a triple modified p53 containing DNA vaccine to enhance processing and presentation of the p53 antigen
|
Hospers, Geke A.P.
|
|
2009
|
28 |
Supplement 2 |
p. 386-391
6 p.
|
artikel
|
| 37 |
Control of EHV-1 viremia and nasal shedding by commercial vaccines
|
Goehring, L.S.
|
|
2010
|
28 |
Supplement 2 |
p. 5203-5211
9 p.
|
artikel
|
| 38 |
Control of Streptococcus pneumoniae serotype 5 epidemic of severe pneumonia among young army recruits by mass antibiotic treatment and vaccination
|
Balicer, Ran D.
|
|
2010
|
28 |
Supplement 2 |
p. 5591-5596
6 p.
|
artikel
|
| 39 |
Development and immunogenicity of a recombinant pseudorabies virus expressing Sj26GST and SjFABP from Schistosoma japonicum
|
Wei, Feng
|
|
2010
|
28 |
Supplement 2 |
p. 5161-5166
6 p.
|
artikel
|
| 40 |
Development of a novel viral DNA vaccine against human papillomavirus: AcHERV-HP16L1
|
Lee, Hee-Jung
|
|
2010
|
28 |
Supplement 2 |
p. 1613-1619
7 p.
|
artikel
|
| 41 |
Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys
|
Clements, David E.
|
|
2010
|
28 |
Supplement 2 |
p. 2705-2715
11 p.
|
artikel
|
| 42 |
Development of a simple and high-yielding fed-batch process for the production of influenza vaccines
|
Meghrous, Jamal
|
|
2009
|
28 |
Supplement 2 |
p. 309-316
8 p.
|
artikel
|
| 43 |
Development of novel lipidated analogs of picroside as vaccine adjuvants: Acylated analogs of picroside-II elicit strong Th1 and Th2 response to ovalbumin in mice
|
Kumar, H.M. Sampath
|
|
2010
|
28 |
Supplement 2 |
p. 8327-8337
11 p.
|
artikel
|
| 44 |
Differential activation of host cell signalling pathways through infection with two variants of influenza A/Puerto Rico/8/34 (H1N1) in MDCK cells
|
Heynisch, B.
|
|
2010
|
28 |
Supplement 2 |
p. 8210-8218
9 p.
|
artikel
|
| 45 |
Display of neutralizing epitopes of Canine parvovirus and a T-cell epitope of the fusion protein of Canine distemper virus on chimeric tymovirus-like particles and its use as a vaccine candidate both against Canine parvo and Canine distemper
|
Chandran, Dev
|
|
2009
|
28 |
Supplement 2 |
p. 132-139
8 p.
|
artikel
|
| 46 |
DNA-mediated vaccination conferring protection against infectious bursal disease in broiler chickens in the presence of maternal antibody
|
Hsieh, Ming Kun
|
|
2010
|
28 |
Supplement 2 |
p. 3936-3943
8 p.
|
artikel
|
| 47 |
DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge
|
Kask, Angela Shaulov
|
|
2010
|
28 |
Supplement 2 |
p. 7483-7491
9 p.
|
artikel
|
| 48 |
Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI®
|
Vilaplana, C.
|
|
2010
|
28 |
Supplement 2 |
p. 1106-1116
11 p.
|
artikel
|
| 49 |
Dual expression system for assembling phage lambda display particle (LDP) vaccine to porcine Circovirus 2 (PCV2)
|
Hayes, Sidney
|
|
2010
|
28 |
Supplement 2 |
p. 6789-6799
11 p.
|
artikel
|
| 50 |
Duration of Vi antibodies in participants vaccinated with Typhim Vi (Typhoid Vi polysaccharide vaccine) in an area not endemic for typhoid fever
|
Froeschle, James E.
|
|
2010
|
28 |
Supplement 2 |
p. 1451-1453
3 p.
|
artikel
|
| 51 |
Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme
|
Harboe, Zitta B.
|
|
2010
|
28 |
Supplement 2 |
p. 2642-2647
6 p.
|
artikel
|
| 52 |
Effectiveness of intranasal vaccination against Angiostrongylus costaricensis using a serine/threonine phosphatase 2 A synthetic peptide and recombinant antigens
|
Solano-Parada, J.
|
|
2010
|
28 |
Supplement 2 |
p. 5185-5196
12 p.
|
artikel
|
| 53 |
Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan
|
Kawakami, Kenji
|
|
2010
|
28 |
Supplement 2 |
p. 7063-7069
7 p.
|
artikel
|
| 54 |
Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA
|
Desai, Sachin N.
|
|
2010
|
28 |
Supplement 2 |
p. 7501-7506
6 p.
|
artikel
|
| 55 |
Effect of human serum on de-N-acetyl sialic acid epitope expression and antibody activity against N. meningitidis group B
|
Flitter, Becca A.
|
|
2010
|
28 |
Supplement 2 |
p. 5967-5972
6 p.
|
artikel
|
| 56 |
Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study
|
Palmer, Liisa A.
|
|
2010
|
28 |
Supplement 2 |
p. 5049-5056
8 p.
|
artikel
|
| 57 |
Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age
|
Prymula, Roman
|
|
2009
|
28 |
Supplement 2 |
p. 71-78
8 p.
|
artikel
|
| 58 |
Effects of astragalus polysaccharides on immunologic function of erythrocyte in chickens infected with infectious bursa disease virus
|
Jiang, Junbing
|
|
2010
|
28 |
Supplement 2 |
p. 5614-5616
3 p.
|
artikel
|
| 59 |
Effects of maternal plasmid GHRH treatment on offspring growth
|
Khan, Amir S.
|
|
2010
|
28 |
Supplement 2 |
p. 1905-1910
6 p.
|
artikel
|
| 60 |
Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C
|
Lee, Sangun
|
|
2010
|
28 |
Supplement 2 |
p. 6658-6665
8 p.
|
artikel
|
| 61 |
Efficacy of 7-valent pneumococcal conjugate vaccination in Germany: An analysis using the indirect cohort method
|
Rückinger, Simon
|
|
2010
|
28 |
Supplement 2 |
p. 5012-5016
5 p.
|
artikel
|
| 62 |
Efficiency of inactivated vaccines against heartwater in Burkina Faso: Impact of Ehrlichia ruminantium genetic diversity
|
Adakal, Hassane
|
|
2010
|
28 |
Supplement 2 |
p. 4573-4580
8 p.
|
artikel
|
| 63 |
Eimeria maxima recombinant Gam82 gametocyte antigen vaccine protects against coccidiosis and augments humoral and cell-mediated immunity
|
Jang, Seung I.
|
|
2010
|
28 |
Supplement 2 |
p. 2980-2985
6 p.
|
artikel
|
| 64 |
Electroporation enhances immune responses and protection induced by a bovine viral diarrhea virus DNA vaccine in newborn calves with maternal antibodies
|
van Drunen Littel-van den Hurk, Sylvia
|
|
2010
|
28 |
Supplement 2 |
p. 6445-6454
10 p.
|
artikel
|
| 65 |
Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens
|
Li, Lijin
|
|
2010
|
28 |
Supplement 2 |
p. 1911-1918
8 p.
|
artikel
|
| 66 |
Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis
|
Nagill, Rajeev
|
|
2010
|
28 |
Supplement 2 |
p. 4002-4012
11 p.
|
artikel
|
| 67 |
Erysipelothrix rhusiopathiae: Association of Spa-type with serotype and role in protective immunity
|
Ingebritson, Alaina L.
|
|
2010
|
28 |
Supplement 2 |
p. 2490-2496
7 p.
|
artikel
|
| 68 |
Evaluation of hepatic changes and local and systemic immune responses in goats immunized with recombinant Peroxiredoxin (Prx) and challenged with Fasciola hepatica
|
Mendes, Ricardo E.
|
|
2010
|
28 |
Supplement 2 |
p. 2832-2840
9 p.
|
artikel
|
| 69 |
Evaluation of serological trials submitted for annual re-licensure of influenza vaccines to regulatory authorities between 1992 and 2002
|
Voordouw, A.C.G.
|
|
2009
|
28 |
Supplement 2 |
p. 392-397
6 p.
|
artikel
|
| 70 |
Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep
|
Dungu, Baptiste
|
|
2010
|
28 |
Supplement 2 |
p. 4581-4587
7 p.
|
artikel
|
| 71 |
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development
|
Franco, David
|
|
2010
|
28 |
Supplement 2 |
p. 5676-5685
10 p.
|
artikel
|
| 72 |
Experimental iron-inactivated Pasteurella multocida A: 1 vaccine adjuvanted with bacterial DNA is safe and protects chickens from fowl cholera
|
Herath, Chitra
|
|
2010
|
28 |
Supplement 2 |
p. 2284-2289
6 p.
|
artikel
|
| 73 |
Factors influencing HPV vaccination status in a Latino population; and parental attitudes towards vaccine mandates
|
Yeganeh, Nava
|
|
2010
|
28 |
Supplement 2 |
p. 4186-4191
6 p.
|
artikel
|
| 74 |
Feasibility of single-shot H5N1 influenza vaccine in ferrets, macaques and rabbits
|
Heldens, J.G.M.
|
|
2010
|
28 |
Supplement 2 |
p. 8125-8131
7 p.
|
artikel
|
| 75 |
Folding domains within the ricin toxin A subunit as targets of protective antibodies
|
O’Hara, Joanne M.
|
|
2010
|
28 |
Supplement 2 |
p. 7035-7046
12 p.
|
artikel
|
| 76 |
Generation of heterogeneous memory T cells by live attenuated tularemia vaccine in humans
|
Salerno-Gonçalves, Rosangela
|
|
2009
|
28 |
Supplement 2 |
p. 195-206
12 p.
|
artikel
|
| 77 |
Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model
|
Yamamoto, Sakura
|
|
2010
|
28 |
Supplement 2 |
p. 6684-6691
8 p.
|
artikel
|
| 78 |
Genetic control of immune responses to influenza A matrix 2 protein (M2)
|
Misplon, Julia A.
|
|
2010
|
28 |
Supplement 2 |
p. 5817-5827
11 p.
|
artikel
|
| 79 |
Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys
|
Schaap-Nutt, Anne
|
|
2010
|
28 |
Supplement 2 |
p. 2788-2798
11 p.
|
artikel
|
| 80 |
Hepatitis B virus (HBV)-derived DRB1*0101-restricted CD4 T-cell epitopes help in the development of HBV-specific CD8+ T cells in vivo
|
Bayard, Florence
|
|
2010
|
28 |
Supplement 2 |
p. 3818-3826
9 p.
|
artikel
|
| 81 |
High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects
|
Potsch, D.V.
|
|
2010
|
28 |
Supplement 2 |
p. 1447-1450
4 p.
|
artikel
|
| 82 |
HIV-2 capsids distinguish high and low virus load patients in a West African community cohort
|
Onyango, Clayton O.
|
|
2010
|
28 |
Supplement 2 |
p. B60-B67
nvt p.
|
artikel
|
| 83 |
HPV vaccine for adolescent males: Acceptability to parents post-vaccine licensure
|
Reiter, Paul L.
|
|
2010
|
28 |
Supplement 2 |
p. 6292-6297
6 p.
|
artikel
|
| 84 |
HSP65 serves as an immunogenic carrier for a diabetogenic peptide P277 inducing anti-inflammatory immune response in NOD mice by nasal administration
|
Liang, Jin
|
|
2010
|
28 |
Supplement 2 |
p. 3312-3317
6 p.
|
artikel
|
| 85 |
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220
|
Overton, E.T.
|
|
2010
|
28 |
Supplement 2 |
p. 5597-5604
8 p.
|
artikel
|
| 86 |
Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae
|
Pérez-Martín, Eva
|
|
2010
|
28 |
Supplement 2 |
p. 2340-2349
10 p.
|
artikel
|
| 87 |
Immunity to Trop-1, a newly identified breast cancer antigen, inhibits the growth of breast cancer in mice
|
Lee, Byeong C.
|
|
2010
|
28 |
Supplement 2 |
p. 7757-7763
7 p.
|
artikel
|
| 88 |
Immunization decision-making in the Republic of Korea: The structure and functioning of the Korea Advisory Committee on Immunization Practices
|
Cho, Hee-Yeon
|
|
2010
|
28 |
Supplement 2 |
p. A91-A95
nvt p.
|
artikel
|
| 89 |
Immunization with the attenuated plasmidless Chlamydia trachomatis L2(25667R) strain provides partial protection in a murine model of female genitourinary tract infection
|
Olivares-Zavaleta, Norma
|
|
2010
|
28 |
Supplement 2 |
p. 1454-1462
9 p.
|
artikel
|
| 90 |
Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii
|
Stoyanov, Cristina T.
|
|
2010
|
28 |
Supplement 2 |
p. 4644-4652
9 p.
|
artikel
|
| 91 |
Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents
|
Lu, Chun-Yi
|
|
2010
|
28 |
Supplement 2 |
p. 5864-5870
7 p.
|
artikel
|
| 92 |
Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10–45 years
|
Tregnaghi, Miguel W.
|
|
2010
|
28 |
Supplement 2 |
p. 3595-3601
7 p.
|
artikel
|
| 93 |
Immunogenicity and safety of the human rotavirus vaccine Rotarix™ co-administered with routine infant vaccines following the vaccination schedules in Europe
|
Vesikari, Timo
|
|
2010
|
28 |
Supplement 2 |
p. 5272-5279
8 p.
|
artikel
|
| 94 |
Immunogenicity and some safety features of a VEGF-based cancer therapeutic vaccine in rats, rabbits and non-human primates
|
Morera, Yanelys
|
|
2010
|
28 |
Supplement 2 |
p. 3453-3461
9 p.
|
artikel
|
| 95 |
Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2–10 years of age
|
Black, S.
|
|
2010
|
28 |
Supplement 2 |
p. 657-663
7 p.
|
artikel
|
| 96 |
Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves
|
Xue, Wenzhi
|
|
2010
|
28 |
Supplement 2 |
p. 3784-3792
9 p.
|
artikel
|
| 97 |
Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: Using PRNT50 as an endpoint for immunogenicity
|
Reisler, Ronald B.
|
|
2010
|
28 |
Supplement 2 |
p. 2436-2441
6 p.
|
artikel
|
| 98 |
Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: Attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV
|
Van Rompay, Koen K.A.
|
|
2010
|
28 |
Supplement 2 |
p. 1481-1492
12 p.
|
artikel
|
| 99 |
Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine
|
Even-Or, Orli
|
|
2010
|
28 |
Supplement 2 |
p. 6527-6541
15 p.
|
artikel
|
| 100 |
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection
|
Garibaldi, Manuela
|
|
2010
|
28 |
Supplement 2 |
p. 3609-3616
8 p.
|
artikel
|
| 101 |
Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV
|
Zhang, Rongxin
|
|
2010
|
28 |
Supplement 2 |
p. 5114-5127
14 p.
|
artikel
|
| 102 |
Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytes
|
Brave, Andreas
|
|
2010
|
28 |
Supplement 2 |
p. 2080-2087
8 p.
|
artikel
|
| 103 |
Induction of protective and therapeutic antitumor immunity by a DNA vaccine with C3d as a molecular adjuvant
|
Xu, Gui-lian
|
|
2010
|
28 |
Supplement 2 |
p. 7221-7227
7 p.
|
artikel
|
| 104 |
Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children
|
Lum, Lucy Chai See
|
|
2010
|
28 |
Supplement 2 |
p. 1566-1574
9 p.
|
artikel
|
| 105 |
Innate and acquired immune responses induced by recombinant Lactobacillus casei displaying flagellin-fusion antigen on the cell-surface
|
Kajikawa, Akinobu
|
|
2010
|
28 |
Supplement 2 |
p. 3409-3415
7 p.
|
artikel
|
| 106 |
Intradermal hepatitis B vaccination in non-responders after topical application of imiquimod (Aldara®)
|
Roukens, Anna H.
|
|
2010
|
28 |
Supplement 2 |
p. 4288-4293
6 p.
|
artikel
|
| 107 |
Intramuscular immunization with a vesicular stomatitis virus recombinant expressing the influenza hemagglutinin provides post-exposure protection against lethal influenza challenge
|
Barefoot, Brice E.
|
|
2009
|
28 |
Supplement 2 |
p. 79-89
11 p.
|
artikel
|
| 108 |
Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice
|
Del Campo, Judith
|
|
2010
|
28 |
Supplement 2 |
p. 1193-1200
8 p.
|
artikel
|
| 109 |
Intranasal immunization with Leish-111f induces IFN-γ production and protects mice from Leishmania major infection
|
Sakai, Shun-ichi
|
|
2010
|
28 |
Supplement 2 |
p. 2207-2213
|
artikel
|
| 110 |
In vitro stimulation of human influenza-specific CD8+ T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine
|
Song, Haifeng
|
|
2010
|
28 |
Supplement 2 |
p. 5524-5532
9 p.
|
artikel
|
| 111 |
IRX-2 increases the T cell-specific immune response to protein/peptide vaccines
|
Naylor, Paul H.
|
|
2010
|
28 |
Supplement 2 |
p. 7054-7062
9 p.
|
artikel
|
| 112 |
J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells
|
Taylor, P.R.
|
|
2010
|
28 |
Supplement 2 |
p. 5533-5542
10 p.
|
artikel
|
| 113 |
Liposomal gD ectodomain (gD1–306) vaccine protects against HSV2 genital or rectal infection of female and male mice
|
Olson, K.
|
|
2009
|
28 |
Supplement 2 |
p. 548-560
13 p.
|
artikel
|
| 114 |
Liposomal oral DNA vaccine (mycobacterium DNA) elicits immune response
|
Wang, Danan
|
|
2010
|
28 |
Supplement 2 |
p. 3134-3142
9 p.
|
artikel
|
| 115 |
Longitudinal 2 years field study of conventional vaccination against highly pathogenic avian influenza H5N1 in layer hens
|
Rudolf, Miriam
|
|
2010
|
28 |
Supplement 2 |
p. 6832-6840
9 p.
|
artikel
|
| 116 |
Low serum serotype-specific pneumococcal antibody concentrations in young children with Haemophilus influenzae serotype b (Hib) vaccine failure
|
Ladhani, Shamez
|
|
2010
|
28 |
Supplement 2 |
p. 4440-4444
5 p.
|
artikel
|
| 117 |
MCV vaccination in the presence of vaccine-associated Guillain–Barré Syndrome risk: A decision analysis approach
|
Cho, Bo-Hyun
|
|
2010
|
28 |
Supplement 2 |
p. 817-822
6 p.
|
artikel
|
| 118 |
Meningococcal conjugate vaccination among adolescents aged 13–17 years, United States, 2007
|
Lu, Peng-jun
|
|
2010
|
28 |
Supplement 2 |
p. 2350-2355
6 p.
|
artikel
|
| 119 |
Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster
|
Brisson, Marc
|
|
2010
|
28 |
Supplement 2 |
p. 3385-3397
13 p.
|
artikel
|
| 120 |
Modeling the national pediatric vaccine stockpile: Supply shortages, health impacts and cost consequences
|
Shrestha, Sundar S.
|
|
2010
|
28 |
Supplement 2 |
p. 6318-6332
15 p.
|
artikel
|
| 121 |
Murine neutralizing antibody response and toxicity to synthetic peptides derived from E1 and E2 proteins of hepatitis C virus
|
El-Awady, Mostafa K.
|
|
2010
|
28 |
Supplement 2 |
p. 8338-8344
7 p.
|
artikel
|
| 122 |
National Immunization Technical Advisory Groups (NITAGs): Guidance for their establishment and strengthening
|
Duclos, Philippe
|
|
2010
|
28 |
Supplement 2 |
p. A18-A25
nvt p.
|
artikel
|
| 123 |
Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7
|
Mohawk, Krystle L.
|
|
2010
|
28 |
Supplement 2 |
p. 4777-4785
9 p.
|
artikel
|
| 124 |
Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7
|
Adachi, Katsuyuki
|
|
2010
|
28 |
Supplement 2 |
p. 2810-2817
8 p.
|
artikel
|
| 125 |
Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria
|
Tobias, Joshua
|
|
2010
|
28 |
Supplement 2 |
p. 6977-6984
8 p.
|
artikel
|
| 126 |
Pandemic influenza in Canadian children: A summary of hospitalized pediatric cases
|
Bettinger, Julie A.
|
|
2010
|
28 |
Supplement 2 |
p. 3180-3184
5 p.
|
artikel
|
| 127 |
Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand
|
Poovorawan, Yong
|
|
2010
|
28 |
Supplement 2 |
p. 730-736
7 p.
|
artikel
|
| 128 |
Pharmacoeconomic evaluation of 10- and 13-valent pneumococcal conjugate vaccines
|
Chuck, Anderson W.
|
|
2010
|
28 |
Supplement 2 |
p. 5485-5490
6 p.
|
artikel
|
| 129 |
Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults
|
Pierce, Mark A.
|
|
2010
|
28 |
Supplement 2 |
p. 2236-2242
|
artikel
|
| 130 |
Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities
|
Yu, Yongxin
|
|
2010
|
28 |
Supplement 2 |
p. 3635-3641
7 p.
|
artikel
|
| 131 |
Population-based analysis of Actinobacillus pleuropneumoniae ApxIVA for use as a DIVA antigen
|
O’Neill, Ciaragh
|
|
2010
|
28 |
Supplement 2 |
p. 4871-4874
4 p.
|
artikel
|
| 132 |
Porcine lactoferrin administration enhances peripheral lymphocyte proliferation and assists infectious bursal disease vaccination in native chickens
|
Hung, Che-Ming
|
|
2010
|
28 |
Supplement 2 |
p. 2895-2902
8 p.
|
artikel
|
| 133 |
Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer
|
Krashias, George
|
|
2010
|
28 |
Supplement 2 |
p. 2482-2489
8 p.
|
artikel
|
| 134 |
Potential epidemiological and economical impact of two rotavirus vaccines in Colombia
|
De la Hoz, Fernando
|
|
2010
|
28 |
Supplement 2 |
p. 3856-3864
9 p.
|
artikel
|
| 135 |
Predictors of universal influenza vaccination uptake in grades 1 and 2 Toronto school children: Effective vaccination strategies should not end with at risk children
|
Foty, Richard G.
|
|
2010
|
28 |
Supplement 2 |
p. 6518-6522
5 p.
|
artikel
|
| 136 |
Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity
|
Machado, Alexandre V.
|
|
2010
|
28 |
Supplement 2 |
p. 3247-3256
10 p.
|
artikel
|
| 137 |
Production and antigenic properties of influenza virus from suspension MDCK-siat7e cells in a bench-scale bioreactor
|
Chu, Chia
|
|
2010
|
28 |
Supplement 2 |
p. 7193-7201
9 p.
|
artikel
|
| 138 |
Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein
|
Zhou, Xuemei
|
|
2010
|
28 |
Supplement 2 |
p. 3990-3996
7 p.
|
artikel
|
| 139 |
Protein typing of major outer membrane lipoproteins from Chinese pathogenic Leptospira spp. and characterization of their immunogenicity
|
Luo, Dongjiao
|
|
2009
|
28 |
Supplement 2 |
p. 243-255
13 p.
|
artikel
|
| 140 |
Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccines
|
Wysocki, J.
|
|
2010
|
28 |
Supplement 2 |
p. 7779-7786
8 p.
|
artikel
|
| 141 |
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection
|
Cummings, James F.
|
|
2010
|
28 |
Supplement 2 |
p. 5135-5144
10 p.
|
artikel
|
| 142 |
Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit
|
Valentin, Antonio
|
|
2010
|
28 |
Supplement 2 |
p. 1962-1974
13 p.
|
artikel
|
| 143 |
RotaTeq®, a pentavalent rotavirus vaccine: Efficacy and safety among infants in Europe
|
Vesikari, Timo
|
|
2009
|
28 |
Supplement 2 |
p. 345-351
7 p.
|
artikel
|
| 144 |
Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO® (IC51), in 6 months of follow-up
|
Dubischar-Kastner, Katrin
|
|
2010
|
28 |
Supplement 2 |
p. 6463-6469
7 p.
|
artikel
|
| 145 |
Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults
|
Treanor, John J.
|
|
2010
|
28 |
Supplement 2 |
p. 8268-8274
7 p.
|
artikel
|
| 146 |
Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers
|
Tribble, D.
|
|
2010
|
28 |
Supplement 2 |
p. 6076-6085
10 p.
|
artikel
|
| 147 |
Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy
|
Russell, F.M.
|
|
2010
|
28 |
Supplement 2 |
p. 3086-3094
9 p.
|
artikel
|
| 148 |
Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster
|
Mills, Richard
|
|
2010
|
28 |
Supplement 2 |
p. 4204-4209
6 p.
|
artikel
|
| 149 |
Salmonella enterica serovar Typhimurium ruvB mutant can confer protection against salmonellosis in mice
|
Choi, Jeongjoon
|
|
2010
|
28 |
Supplement 2 |
p. 6436-6444
9 p.
|
artikel
|
| 150 |
Selection and identification of malaria vaccine target molecule using bioinformatics and DNA vaccination
|
Shuaibu, M.N.
|
|
2010
|
28 |
Supplement 2 |
p. 6868-6875
8 p.
|
artikel
|
| 151 |
Seroconversion following incomplete human rabies postexposure prophylaxis
|
Robertson, Kis
|
|
2010
|
28 |
Supplement 2 |
p. 6523-6526
4 p.
|
artikel
|
| 152 |
Single versus multi-dose vaccine vials: An economic computational model
|
Lee, Bruce Y.
|
|
2010
|
28 |
Supplement 2 |
p. 5292-5300
9 p.
|
artikel
|
| 153 |
Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant
|
Xue, Xiangyang
|
|
2010
|
28 |
Supplement 2 |
p. 3152-3158
7 p.
|
artikel
|
| 154 |
Standardization and validation of assays determining cellular immune responses against influenza
|
Gijzen, Karlijn
|
|
2010
|
28 |
Supplement 2 |
p. 3416-3422
7 p.
|
artikel
|
| 155 |
Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems
|
Leroux-Roels, Isabel
|
|
2010
|
28 |
Supplement 2 |
p. 7016-7024
9 p.
|
artikel
|
| 156 |
Structure–activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2
|
Zaman, Mehfuz
|
|
2010
|
28 |
Supplement 2 |
p. 2243-2248
|
artikel
|
| 157 |
Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region
|
Lin, Tzou-Yien
|
|
2010
|
28 |
Supplement 2 |
p. 7589-7605
17 p.
|
artikel
|
| 158 |
Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women
|
De Carvalho, N.
|
|
2010
|
28 |
Supplement 2 |
p. 6247-6255
9 p.
|
artikel
|
| 159 |
Swine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolates
|
Kitikoon, Pravina
|
|
2009
|
28 |
Supplement 2 |
p. 523-531
9 p.
|
artikel
|
| 160 |
Systematic review of interventions to increase influenza vaccination rates of those 60 years and older
|
Thomas, Roger E.
|
|
2010
|
28 |
Supplement 2 |
p. 1684-1701
18 p.
|
artikel
|
| 161 |
The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs
|
Bernstein, David I.
|
|
2010
|
28 |
Supplement 2 |
p. 3748-3753
6 p.
|
artikel
|
| 162 |
The association of ethnicity with antibody responses to pneumococcal vaccination among adults with HIV infection
|
Crum-Cianflone, Nancy F.
|
|
2010
|
28 |
Supplement 2 |
p. 7583-7588
6 p.
|
artikel
|
| 163 |
The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice
|
Chen, Xiaohua
|
|
2010
|
28 |
Supplement 2 |
p. 3913-3919
7 p.
|
artikel
|
| 164 |
The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of current literature
|
Alavian, Seyed-Moayed
|
|
2010
|
28 |
Supplement 2 |
p. 3773-3777
5 p.
|
artikel
|
| 165 |
The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007
|
Bettinger, Julie A.
|
|
2010
|
28 |
Supplement 2 |
p. 2130-2136
7 p.
|
artikel
|
| 166 |
The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox
|
Heinsbroek, Ellen
|
|
2010
|
28 |
Supplement 2 |
p. 3778-3783
6 p.
|
artikel
|
| 167 |
The immunization-induced antibody response to the Anaplasma marginale major surface protein 2 and its association with protective immunity
|
Noh, Susan M.
|
|
2010
|
28 |
Supplement 2 |
p. 3741-3747
7 p.
|
artikel
|
| 168 |
The need for quadrivalent vaccine against seasonal influenza
|
Belshe, Robert B.
|
|
2010
|
28 |
Supplement 2 |
p. D45-D53
nvt p.
|
artikel
|
| 169 |
The potential value of Clostridium difficile vaccine: An economic computer simulation model
|
Lee, Bruce Y.
|
|
2010
|
28 |
Supplement 2 |
p. 5245-5253
9 p.
|
artikel
|
| 170 |
The RTS,S malaria vaccine
|
Casares, Sofia
|
|
2010
|
28 |
Supplement 2 |
p. 4880-4894
15 p.
|
artikel
|
| 171 |
The safety of immunizing with tetanus–diphtheria–acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak
|
Talbot, Elizabeth A.
|
|
2010
|
28 |
Supplement 2 |
p. 8001-8007
7 p.
|
artikel
|
| 172 |
The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunization
|
Masalova, Olga V.
|
|
2010
|
28 |
Supplement 2 |
p. 1987-1996
10 p.
|
artikel
|
| 173 |
Th2-polarisation of cellular immune memory to neonatal pertussis vaccination
|
White, Olivia J.
|
|
2010
|
28 |
Supplement 2 |
p. 2648-2652
5 p.
|
artikel
|
| 174 |
Towards developing standardized protocols for evaluation of cellular mucosal immune responses – Recommendations from a DAIDS/NIH workshop, June 15–16, 2009
|
Mehra, V.
|
|
2010
|
28 |
Supplement 2 |
p. 4689-4694
6 p.
|
artikel
|
| 175 |
Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin
|
Summerton, Nancy A.
|
|
2010
|
28 |
Supplement 2 |
p. 1404-1411
8 p.
|
artikel
|
| 176 |
Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE
|
Trigo, Joelma
|
|
2010
|
28 |
Supplement 2 |
p. 3333-3340
8 p.
|
artikel
|
| 177 |
Type 2 immune-inducing helminth vaccination maintains protective efficacy in the setting of repeated parasite exposures
|
Hübner, Marc P.
|
|
2010
|
28 |
Supplement 2 |
p. 1746-1757
12 p.
|
artikel
|
| 178 |
Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: Meeting at the Crossroads
|
Madore, Dace V.
|
|
2010
|
28 |
Supplement 2 |
p. 4539-4547
9 p.
|
artikel
|
| 179 |
Vaccination against tick-borne encephalitis virus tests specific IgG production ability in patients under immunoglobulin substitution therapy
|
Seidel, Markus G.
|
|
2010
|
28 |
Supplement 2 |
p. 6621-6626
6 p.
|
artikel
|
| 180 |
Vaccination of grouper broodfish (Epinephelus tukula) reduces the risk of vertical transmission by nervous necrosis virus
|
Kai, Yu-Hsuan
|
|
2010
|
28 |
Supplement 2 |
p. 996-1001
6 p.
|
artikel
|
| 181 |
Vaccination strategies for managing brucellosis in Yellowstone bison
|
Treanor, John J.
|
|
2010
|
28 |
Supplement 2 |
p. F64-F72
nvt p.
|
artikel
|
| 182 |
Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: Implication for treatment of periodontal infection and halitosis
|
Liu, Pei-Feng
|
|
2010
|
28 |
Supplement 2 |
p. 3496-3505
10 p.
|
artikel
|
| 183 |
Vaccination with peptide mimotopes produces antibodies recognizing bacterial capsular polysaccharides
|
Wu, Yang
|
|
2010
|
28 |
Supplement 2 |
p. 6425-6435
11 p.
|
artikel
|
| 184 |
Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras
|
Ellingson, Joshua S.
|
|
2010
|
28 |
Supplement 2 |
p. 2679-2686
8 p.
|
artikel
|
| 185 |
7-Valent pneumococcal conjugate vaccine and lower respiratory tract infections: Effectiveness of a 2-dose versus 3-dose primary series
|
Pelton, Stephen I.
|
|
2010
|
28 |
Supplement 2 |
p. 1575-1582
8 p.
|
artikel
|
| 186 |
Vaxfectin® enhances both antibody and in vitro T cell responses to each component of a 5-gene Plasmodium falciparum plasmid DNA vaccine mixture administered at low doses
|
Sedegah, Martha
|
|
2010
|
28 |
Supplement 2 |
p. 3055-3065
11 p.
|
artikel
|
| 187 |
Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs
|
Senger, Tilo
|
|
2010
|
28 |
Supplement 2 |
p. 1583-1593
11 p.
|
artikel
|
| 188 |
VP5-deficient mutant virus induced protection against challenge with very virulent infectious bursal disease virus of chickens
|
Qin, Liting
|
|
2010
|
28 |
Supplement 2 |
p. 3735-3740
6 p.
|
artikel
|
Tijdschrift beschrijving